» Articles » PMID: 36879969

Structural Insights and Shedding Light on Preferential Interactions of Dietary Flavonoids with G-quadruplex DNA Structures: A New Horizon

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Mar 7
PMID 36879969
Authors
Affiliations
Soon will be listed here.
Abstract

G-quadruplex, a structurally unique structure in nucleic acids present all throughout the human genome, has sparked great attention in therapeutic investigations. Targeting G-quadruplex structure is a new strategy for the drug development. Flavonoids are found in almost all dietary plant-based beverages and food products; therefore, they are ingested in significant proportions through the human diet. Although synthetically developed drug molecules are used vigorously but they have various adverse effects. While on the other hand, nature supplies chemically unique scaffolds in the form of distinct dietary flavonoids that are easily accessible, less poisonous, and have higher bioavailability. Because of their great pharmacological effectiveness and minimal cytotoxicity, such low molecular weight compounds are feasible alternatives to synthetic therapeutic medicines. Therefore, from a drug-development point of view, investigation on screening the binding capabilities of quadruplex-interactive small natural compounds like dietary flavonoids are expected to be highly effective, with a particular emphasis on the selectivity towards polymorphic G-quadruplex structures. In this respect, quadruplexes have scintillated research into their potential interaction with these dietary flavonoids. The purpose of this review is to offer an up-to-date close-up look at the research on their interaction with structurally varied dietary flavonoids with the goal of providing newer perspectives to construct novel therapeutic agents for next-generation disease managements.

Citing Articles

Phytochemicals in Drug Discovery-A Confluence of Tradition and Innovation.

Chihomvu P, Ganesan A, Gibbons S, Woollard K, Hayes M Int J Mol Sci. 2024; 25(16).

PMID: 39201478 PMC: 11354359. DOI: 10.3390/ijms25168792.


Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies.

Chunarkar-Patil P, Kaleem M, Mishra R, Ray S, Ahmad A, Verma D Biomedicines. 2024; 12(1).

PMID: 38255306 PMC: 10813144. DOI: 10.3390/biomedicines12010201.


Binding of Quercetin Derivatives toward G-Tetrads as Studied by the Survival Yield Method.

Stezycka O, Franska M ACS Omega. 2023; 8(42):39816-39821.

PMID: 37901583 PMC: 10600882. DOI: 10.1021/acsomega.3c06016.


Non-canonical DNA structures in the human ribosomal DNA.

Smirnov E, Molinova P, Chmurciakova N, Vacik T, Cmarko D Histochem Cell Biol. 2023; 160(6):499-515.

PMID: 37750997 DOI: 10.1007/s00418-023-02233-1.


Prolidase-proline oxidase axis is engaged in apoptosis induction by birch buds flavonol santin in endometrial adenocarcinoma cell line.

Szoka L, Nazaruk J, Giegiel J, Isidorov V Front Mol Biosci. 2023; 10:1247536.

PMID: 37745688 PMC: 10512030. DOI: 10.3389/fmolb.2023.1247536.


References
1.
Dretcanu G, Stirbu I, Leoplold N, Cruceriu D, Danciu C, Stanila A . Chemical Structure, Sources and Role of Bioactive Flavonoids in Cancer Prevention: A Review. Plants (Basel). 2022; 11(9). PMC: 9101215. DOI: 10.3390/plants11091117. View

2.
Rouleau S, Glouzon J, Brumwell A, Bisaillon M, Perreault J . 3' UTR G-quadruplexes regulate miRNA binding. RNA. 2017; 23(8):1172-1179. PMC: 5513062. DOI: 10.1261/rna.060962.117. View

3.
Ezzati M, Yousefi B, Velaei K, Safa A . A review on anti-cancer properties of Quercetin in breast cancer. Life Sci. 2020; 248:117463. DOI: 10.1016/j.lfs.2020.117463. View

4.
Valton A, Hassan-Zadeh V, Lema I, Boggetto N, Alberti P, Saintome C . G4 motifs affect origin positioning and efficiency in two vertebrate replicators. EMBO J. 2014; 33(7):732-46. PMC: 4000090. DOI: 10.1002/embj.201387506. View

5.
Shu H, Zhang R, Xiao K, Yang J, Sun X . G-Quadruplex-Binding Proteins: Promising Targets for Drug Design. Biomolecules. 2022; 12(5). PMC: 9138358. DOI: 10.3390/biom12050648. View